Dr. Raonak Karnde is an accomplished medical affairs leader, physician, and strategic healthcare professional currently serving as Cluster Head – Medical Affairs at Gennova Biopharmaceuticals, one of India’s leading innovation-driven biopharmaceutical organizations. With a career built at the intersection of clinical medicine, oncology, scientific communication, and pharmaceutical leadership, Dr. Karnde has established himself as a dynamic force in translating complex science into meaningful clinical impact. His professional mission is rooted in ensuring that breakthrough therapies are supported by robust scientific evidence, physician engagement, and patient-centric innovation, helping bridge the gap between research excellence and real-world healthcare outcomes.

At Gennova Biopharmaceuticals, Dr. Karnde leads the Medical Affairs function across critical therapeutic clusters including hematology, oncology, and ophthalmology, guiding scientific strategy, evidence generation, key opinion leader engagement, and cross-functional collaboration. Under his leadership, the medical affairs team has expanded significantly, with a strong focus on building scientific credibility, nurturing medical talent, and aligning clinical innovation with patient needs. In recent leadership announcements, he was elevated to Cluster Lead – Oncology and Ophthalmology, reflecting his growing influence within Gennova’s leadership ecosystem.

A medical doctor by training, Dr. Karnde combines clinical expertise with deep pharmaceutical domain knowledge across oncology and specialty medicine. Throughout his career, he has worked extensively in evidence-based medical communication, strategic scientific partnerships, product lifecycle support, and physician education. He is widely respected for building high-performance medical teams from the ground up, fostering a culture centered on “honest science, meaningful conversations, and patient responsibility,” as reflected in his recent leadership communications at Gennova.

Beyond operational leadership, Dr. Karnde is an active thought leader in oncology innovation, clinical data interpretation, and translational medicine, frequently sharing insights on emerging global clinical developments. Through his work at Gennova Biopharmaceuticals, he continues to strengthen India’s biopharmaceutical innovation ecosystem while helping deliver cutting-edge therapies that improve patient outcomes and advance the future of precision healthcare.